• Events
  • Events
  • Melanoma Focus Virtual Regional Meeting 2021

Melanoma Focus Virtual Regional Meeting 2021

We are delighted to announce that registration is now open for this year’s Melanoma Focus Virtual Regional Meeting. The event is organised by Dr. Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust.

The Federation of the Royal Colleges of Physicians of the United Kingdom (RCP UK) and the Royal College of Surgeons of England (RCS Eng) have both awarded upto 6 CME points and the British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS) has awarded upto 8 CME points.

If you are unsure about your membership, please contact Michelle at mbridge@melanomafocus.com.

2021 Registration Fees:

Member
Consultant £79
Other Clinician £59
Nurse / AHP / Retired £35
Non-Member
Consultant £119
Other Clinician £75
Nurse / AHP / Retired £55
Industry £149

2021 Draft Programme:

09:00 – 09:15 Welcome & Melanoma Focus Business Meeting
Mark Harries, Chairman Melanoma Focus/Susanna Daniels
09:15 – 12:15 Pharma Exhibition Area
09:20 – 10:00 Meet the Expert (Professor Christian Ottensmeier) RNA vaccines and IO
10:10 – 10:50 Virtual Networking x 4 concurrent (Surgeons/Dermatologists/Oncologists/CNS)

CNSs – ‘Living with Uncertainty’ facilitated by Alice Bentley, Clinical Psychologist, Maggie’s Newcastle and Helen Moorey
Dermatologists – ‘Developing National Guidelines for Skin Toxicity’ facilitated by Andy Muinonen-Martin
Oncologists – ‘The Challenges of Conducting Trials in the Covid era’ facilitated by Pippa Corrie and Sarah Danson
Surgeons – ‘Future Surgical Research’ facilitated by Rowan Pritchard-Jones

11:00 – 12:00 Novartis Sponsored Symposium
12:20 – 12:25 Welcome
Dr Matthew Wheater (Organiser), Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust
12:25 – 14:00 Session 1: Immunotherapy Toxicity
12:25 – 12:30 Session 1: Immunotherapy Toxicity
Dr Joe Sacco, Consultant Medical Oncologist, Clatterbridge Cancer Centre
12:30 – 12:55 Immunotherapy toxicity – a patient’s story
Helen Moorey, Lead Skin Cancer CNS, University Hospital Southampton
Ian Goddard, Melanoma Patient
12:55 – 13:20 Managing immunotherapy toxicity – the Clatterbridge experience
Dr Anna Olson-Brown, MRC Clinical Research Fellow, Clatterbridge Cancer Centre
13:20 – 13:45 Recognising and managing skin toxicity from checkpoint inhibitors
Dr Louise Fearfield, Consultant Dermatologist, Royal Marsden Hospital
13:45 – 14:00 Q & A
14:00 – 14:10 Comfort Break
14:10 – 16:00 Session 2: Future Directions of Immunotherapy and Mechanisms of Resistance
14.10 – 14.15 Session 2: Future Directions of Immunotherapy and Mechanisms of Resistance
Chair: Dr Matthew Wheater
14:10 – 14:15 The future of immunotherapy – checkpoint inhibitors and beyond
Professor Christian Ottensmeier, Professor of Immuno-Oncology, Liverpool Head and Neck Centre & Clatterbridge Cancer Centre NHS Foundation Trust
14:55 – 15:40 PD1 Inhibition – a double-edged sword? Hyperprogression and resistance to immunotherapy
Dr Simon Eschweiler, La Jolla Institute for Immunology, California
15:40 – 16:00 Q&A
   
16:00 – 16:10 Comfort Break
16:10 – 16:50 Session 3: Advanced Ocular Melanoma – case driven discussion
Chair: Dr Ioannis Karydis, Consultant Medical Oncologist, University Hospital Southampton
Mr Arjun Takhar, Consultant Hepatobiliary Surgeon, University Hospital Southampton
Dr Sachin Modi, Consultant Interventional Radiologist, University Hospital Southampton
Dr Paul Nathan, Consultant Medical Oncologist, Mt Vernon Cancer Centre
16:55 – 17:40 Session 4: Locally-Advanced Disease – MDT
Chair: Mr Howard Peach, Consultant Plastic Surgeon, Leeds Teaching Hospitals NHS Trust
Mr Mansoor Khan, Consultant Plastic Surgeon, University Hospital Southampton
Mr Andrew Hayes, Consultant Surgical Oncologist, Royal Marsden Hospital
Dr Sophie Papa, Clinical Reader, King’s College London and Honorary Consultant
Medical Oncologist, Guy’s and St Thomas’ NHS Trust.
17:40 – 17:45 Concluding Remarks and Close
Dr Matthew Wheater